Psychiatry Medical News about Cannabis Chronic Disease Opioid-Related Disorders

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Omega-3 fatty acids for bipolar disorder

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The Prevalence and Significance of Cannabis Use in Patients Prescribed Chronic Opioid Therapy: A Review of the Extant Literature
Pain Medicine, 09/30/09

Reisfield GM et al. – Cannabis use is prevalent in patients prescribed chronic opioid therapy and is associated with opioid misuse. Further research is necessary to clarify the strength and the nature of the association between cannabis use and opioid misuse, and to address additional questions about the consequences of cannabis use in the context of chronic opioid therapy.

Methods

PubMed was queried for studies of chronic opioid therapy in which aberrant opioid–related behaviors were quantitatively examined and in which cannabis use data (as determined by cannabinoid–positive urine drug tests) were extricable from that of other substances of abuse.

Results

The prevalence of cannabis use among patients prescribed chronic opioid therapy in these studies ranged from 6.2% to 39%, compared with 5.8% in the general United States population.
Furthermore, cannabis use in chronic opioid patients shows statistically significant associations with present and future aberrant opioid–related behaviors.

<< Previous
Electroconvulsive Therapy: Part I. A Perspective on the Evolution...

Next >>
Childhood loneliness as a predictor of adolescent depressive...